| Authors: |
Long GV; Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia. georgina.long@sydney.edu.au., Garnett-Benson C; Bristol Myers Squibb, Princeton, NJ, USA., Dolfi S; Bristol Myers Squibb, Princeton, NJ, USA., Ascierto PA; Istituto Nazionale dei Tumori IRCCS 'Fondazione G. Pascale', Napoli, Italy., Guo J; Peking University Cancer Hospital & Institute, Beijing, China., Tarhini AA; Moffitt Cancer Center & Research Institute, Tampa, FL, USA., Chandra S; Northwestern University, Chicago, IL, USA., Muñoz-Couselo E; Vall d'Hebron Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., de Melo AC; Brazilian National Cancer Institute, Rio de Janeiro, Brazil., Callahan M; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gogas H; National and Kapodistrian University of Athens, Athens, Greece., Dummer R; University of Zurich, Zurich, Switzerland., Schadendorf D; University Hospital Essen, National Center for Tumor Diseases (NCT-West), Campus Essen, German Cancer Consortium, Campus Essen, and University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany., Koelblinger P; Paracelsus Medical University, Salzburg, Austria., Quereux G; CHU Nantes, Nantes University and Immunology and New Concepts in ImmunoTherapy (INCIT), Nantes, France., Thomas I; EDOEAP, Athens, Greece., Yu JX; Bristol Myers Squibb, Princeton, NJ, USA., Fisher A; Bristol Myers Squibb, Princeton, NJ, USA., Wang B; Bristol Myers Squibb, Princeton, NJ, USA., Djidel P; Bristol Myers Squibb, Princeton, NJ, USA., Chouzy A; Bristol Myers Squibb, Princeton, NJ, USA., Semaan M; Bristol Myers Squibb, Princeton, NJ, USA., Chen B; Bristol Myers Squibb, Princeton, NJ, USA., Cheong AMY; Bristol Myers Squibb, Uxbridge, UK., Tawbi HA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
